indications worldwide

JME
- FDA Approves Keppra for Juvenile Myoclonic Epilepsy Indication

T-C
- EC approves new indication for Keppra® as adjunctive therapy in the treatment of primary generalised tonic-clonic seizures in patients with Idiopathic Generalised Epilepsy
MONOTHERAPY

Pharmatimes reports that Keppra™ (levetiracetam) has been approved in Europe for use as monotherapy for newly diagnosed epilepsy patients with partial onset seizures.

נסיון מתקדם בילדים מתחת לגיל 4

UCB Announces Positive Top-Line Phase III Results for Keppra® as Adjunctive Therapy for Partial Onset Seizures in Paediatric Patients from One Month to Less than Four Years of Age

צורות מתן
- IV - EU Approval For UCB's IV Keppra
- סירופ -

עיצוב ובנייה - Morestyle.biz